BioHealth News
Maryland’s Lt. Governor Miller Leads Maryland Delegation at World’s Largest Biotech Conference
BOSTON, MA – This week, Maryland Lt. Governor Aruna K. Miller led a Maryland delegation to the BIO International Convention in Boston, Massachusetts where she and members of the…
Read More
GEN: Former NIH Director Francis Collins Praises the Institution as He Abruptly Departs After Three Decades
By Kevin Davies, PhD - March 3, 2025 - After an illustrious career including 12 years as director of the National Institutes of Health…
Read More
GEN: FDA Accepts for Review Precigen RRP Gene Therapy Candidate
By Alex Philippidis - February 26, 2025 - The FDA has granted Priority Review to Precigen’s Biologics License Application (BLA) for its lead candidate…
Read More
TNF Pharmaceuticals Launches Phase 2b Trial for First Oral TNF-Alpha Inhibitor to Combat Muscle Loss and Frailty
BALTIMORE--(BUSINESS WIRE)--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory…
Read More
CityBiz – Protenus: From Accelerator to Acquisition
Protenus, a leading healthcare compliance analytics platform that serves over 200 healthcare organizations, was acquired in January 2025 by Bluesight, a prominent provider of inventory management, procurement,…
Read More
TEDCO Announces Investment in Pathotrak
COLUMBIA, Md., (February 25, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced a recent $250,000 Venture Funds investment in Pathotrak. TEDCO’s evergreen…
Read More
NYT: Paying for science
By Benjamin Mueller -The Trump administration stormed into office, loudly firing workers and closing diversity programs. But behind the scenes, it has also brought…
Read More
Alphyn Secures FDA Clearance of Investigational New Drug Application for Atopic Dermatitis Treatment
ANNAPOLIS, Md., Feb. 19, 2025 /PRNewswire/ -- Alphyn, a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics®, announced today that the U.S. Food and Drug Administration (FDA) has…
Read More
CEL-SCI to Initiate Multikine Confirmatory Phase 3 Cancer Trial
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) today announced it is in the final stages for the launch of its 212-patient Confirmatory Registration Study for Multikine*…
Read More
Britecyte’s Adipose Tissue Allograft Earns “Safe to Proceed” Status from FDA
GERMANTOWN, Md.--(BUSINESS WIRE)--Amarex today announced its work on behalf of Britecyte has resulted in a “safe to proceed” status by the United States Food…
Read More
Elixirgen Therapeutics Granted FDA Orphan Drug Designation for EXG-34217 for Treatment of Telomere Biology Disorders
BALTIMORE, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company focused on treating rare diseases, today announced that the U.S.…
Read More
Georgetown Research and Innovation Showcase: Connecting Academia, Industry, and Investors
On April 1, 2025, Georgetown University’s Office of Technology Commercialization, in partnership with the Georgetown Entrepreneurship Initiative, will host the first-ever Georgetown Research and…
Read More
Governor Moore Names Harry Coker, Jr. as Maryland Department of Commerce Secretary
BALTIMORE, MD (January 24, 2025) – Governor Wes Moore today announced the appointment of Harry Coker, Jr. as secretary of the Maryland Department of Commerce. Coker…
Read More
TEDCO Invests in Novel Microdevices
Maryland-founded healthcare company continues to lead in medical diagnostic innovation COLUMBIA, Md., (February 18, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced…
Read More
BHI Board Member Juergen Klenk Discusses the Future of AI in Federal Health with Deloitte AI Institute
The Deloitte AI Institute has launched a new video series, You, Me, and Three: GenAI Questions, featuring industry leaders discussing the rapid transformation of…
Read More